Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Identify dividend ETFs with competitive fees and solid value. Learn key criteria and compare options to optimize your costs today.
27,814 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Boeing stands at greater risk than peers if Elon Musk's Tesla and SpaceX ever join forces, a scenario analysts say co...
In a market flooded with hype, even legendary value investors feel the pinch. This guide explains why Warren Buffett ...
A Sea Limited executive sold $4.4 million in stock but remains one of the company’s biggest stakeholders. This piece ...
A top executive at Urban Outfitters sold a sizable block of stock in a short time frame. This article breaks down wha...
Figma stock has fallen in 2026 as AI-powered competitors gain ground. This guide breaks down whether the decline crea...
As Walmart gears up for 2027, investors need a clear view of how groceries, online sales, and international markets s...
A former Google engineer turned $7.2 AI CEO says the hiring surge is real, but the toughest filter is drive and work ...
Cathie Wood goes bargain moves reflect Ark Invest's hunt for disruptive tech at a discount. Explore three stocks she ...
A major fund recently added a huge stake in Neptune Insurance Holdings, boosting the quarter-end position by over $65...
Berkshire Hathaway kicked off the year with bold portfolio changes. In Q1, the company swapped key holdings and redir...
A regulatory hint sent Moderna stock just popped, but the journey from acceptance to approval matters. This guide bre...